Minor reference to pandemic constitutes implied COVID-19 claim according to recent NAD case
One need not explicitly cite COVID-19 in advertising materials to draw the scrutiny of the National Advertising Division (NAD) of BBB National Programs.
Photo © iStockphoto.com/s-cphoto
One need not explicitly cite COVID-19 in advertising materials to draw the scrutiny of the National Advertising Division (NAD) of BBB National Programs. This was demonstrated when NAD recently challenged an Instagram post from Vitamin Bounty/Matheson Organics LLC for its Elderberry Immune Support. The post read: “[a]s restrictions are gradually lifting, it’s more important than ever to keep your immune system strong. Our Elderberry Immune Support keeps you protected with vitamin C, zinc, elderberries, garlic and echinacea; a powerful immune-boosting combo.”
NAD was concerned that the text implied a claim to treat COVID-19. After Vitamin Bounty did not respond to NAD’s request, the case was referred to FDA and FTC for review, but following the referral, the advertiser responded to NAD and agreed to participate in the advertising self-regulatory forum. Subsequently, Vitamin Bounty agreed to voluntarily discontinue the social media post on Instagram and Facebook.
FDA revokes authorization to use Red No. 3 as a color additive in food or drugs
January 15th 2025FDA contends that the color additive is safe for humans but is legally obligated by the Delaney Clause of the FD&C act to revoke authorization as research shows the Red No. 3 induces cancer in rats.
